The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort - (CNS HAND)
This study has been completed.
Information provided by (Responsible Party):
Dr. Mark Bloch, Holdsworth House Medical Practice
First received: September 14, 2011
Last updated: October 22, 2012
Last verified: October 2012
To determine the prevalence of HIV associated Neurological Disorder (HAND) in a population of HIV positive patients within a primary care setting compared with the HIV negative population. The investigators aim is to assess the use of optimal screening methods to assess HAND. For this the investigators will be comparing the performance of a group of persons who are HIV positive and a group of persons who are HIV negative to test their memory and concentration abilities over-time.
HIV-1-Associated Cognitive Motor Complex
||Observational Model: Cohort
Time Perspective: Prospective
||The CNS HAND Study: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort
Primary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||October 2012 (Final data collection date for primary outcome measure)
Subjects must have documented HIV, be english speaking, with life expectancy greater than 6 months, and must have adequate information available in their medical record to apply HAND predictive algorithm (HIV-associated neurological disease)
Must have documented negative HIV test within 12 months of study entry, have no traumatic brain injury or history of chronic neurological illness/psychiatric conditions (such as bipolar or depression),be english speaking and have no history of drug or alcohol abuse.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients attending Holdsworth House Medical Practice, Sydney, Australia
HIV positive Inclusion Criteria:
- Documented HIV infection
- Able to participate in study procedures
HIV positive Exclusion Criteria:
- Inability to comprehend or read English (as established by the English proficiency questionnaire)
- Drug or alcohol intoxicated (as determined by the investigator)
- Lack of information in medical records to determine the HAND predictive algorithm (current CD4 count, past CNS HIV-related disease, and duration of HIV therapy)
- Life expectancy <6 months
- Inability to attend the clinic for required study follow up visits
HIV-negative Inclusion Criteria:
- Negative HIV-1 test within 12 months of study entry
HIV-negative Exclusion Criteria:
- Life time traumatic brain injury leading to loss of consciousness of at least 30 minutes.
- Inability to comprehend or read English (as established by the English proficiency questionnaire).
- Inability to attend the clinic for required study follow up visits.
- History of chronic neurological illness.
- Unstable psychiatric conditions such as bipolar disorder or depression.
- Individuals with psychiatric disorder on the psychotic axis.
- Active or past (within the last 6 months) severe alcohol or substance abuse sufficient, in the investigator's judgement, to prevent completion of tests or Inability to attend for the planned required study follow up visits.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||Dr. Mark Bloch, Doctor, Holdsworth House Medical Practice
History of Changes
|Other Study ID Numbers:
||CNS HAND Study
|Study First Received:
||September 14, 2011
||October 22, 2012
||Australia: National Health and Medical Research Council
Keywords provided by Holdsworth House Medical Practice:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 26, 2015
AIDS Dementia Complex
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Immune System Diseases
Immunologic Deficiency Syndromes
Nervous System Diseases
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral